REGN
Regeneron Pharmaceuticals Inc
Price:  
985.02 
USD
Volume:  
259,278.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron Probability of Bankruptcy

The Probability of Bankruptcy of Regeneron Pharmaceuticals Inc (REGN) is 1.30% . This number represents the probability that Regeneron will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating Regeneron's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

Regeneron - ESG ratings

ESG ratings are directly linked to the cost of capital and Regeneron's ability to raise funding, both of which can significantly affect the probability of Regeneron Pharmaceuticals Inc going bankrupt.

ESG Score 81.82
Environment Score 99.00
Social Score 99.00
Governance Score 47.45
Returns
Historical Returns (5 day)
Historical Returns (MTD)
Historical Returns (YTD)
Historical Returns (13 week)
Historical Returns (26 week)
Historical Returns (52 week)
Efficiency
Asset Turnover
Receiveable Turnover
Gross Margin
Operating Margin
Pretax Margin
Net Margin
Return on Asset (ROA)
Return on Equity (ROE)
Return on Investments (ROI)
Price Metrics
Market Cap (M) 108,539.35
Enterprise Value (M)
52 Week High
52 Week Low
Beta
Average Volume (10 day)
Average Volume (3 month)
Price / Earnings (P/E)
Price / Sales (P/S)
Earnings
EPS
Revenue CAGR (5 year)
Risk
Current Ratio
Quick Ratio